ENTER


Полный размерЗакрыть
Полный размерЗакрыть
Полный размерЗакрыть
Полный размерЗакрыть

Efficiency of 0.005 % latanoprost / 0.5 % timolol maleate fixed combinations, compared with 1 % brinzolamide / 0.5 % timolol maleate in patients with primary open-angle glaucoma

Details


Zavhorodnia N.H.1, 2, Bezdenezhna O.O.1, 2, Bezdenezhnyi S.V.2
1SI «Zaporizhia Medical Academy of Post-Graduate Education Ministry of Health of Ukraine», Zaporizhia, Ukraine
2Clinic of Modern Ophthalmology «Visus», Zaporizhia, Ukraine


SUMMARY

Objective. To evaluate the efficiency of 0.005 % latanoprost / 0.5 % timolol maleate fixed combinations, compared with 1 % brinzolamide / 0.5 % timolol maleate in patients with primary open-angle glaucoma (POAG).

Methods. In this study 50 eyes of 30 patients with POAG were examined. Fifteen patients (25 eyes) were appointed instillation by 1 % brinzolamide / 0.5 % timolol maleate (AZARGA, Alcon) within 1 month, then without a break in the treatment they were switched to 0.005 % latanoprost / 0.5 % timolol maleate (LANOTAN-T, Farmak) also for 1 month. Patients of the second group opposite at the beginning of treatment were appointed instillation by 0.005 % latanoprost / 0.5 % timolol maleate, and after 1 month were switched to the instillation of 1 % brinzolamide / 0.5 % timolol maleate.

Complex examination in addition to general ophthalmological methods included computer static perimetry and computer sphygmography.

Results. The appointment of a fixed combinations of 0.005 % latanoprost / 0.5 % timolol maleate and 1 % brinzolamide / 0.5 % timolol maleate provides a clinically significant decrease in intraocular presure from baseline level by 31 and 32 %, respectively.

It has been found that the combination of 0.005 % latanoprost / 0.5 % timolol maleate has more expressed neuroprotective effects compared with 1 % brinzolamide / 0.5 % timolol maleate due to improvement of microcirculation.

Keywords: primary open-angle glaucoma, fixed combinations of antihypertensive drugs.

Read more: Efficiency of 0.005 % latanoprost / 0.5 % timolol maleate fixed combinations, compared with 1 %...

Experience of the treatment of diabetic macular edema in patients with diabetes mellitus type II on the background of correction of lipid metabolism

Details


Veselovska N.M.1, 2, Zherebko I.B.1, 2, Kuchar N.V.1, 2
1Kyiv City Ophthalmologic Center, Kyiv City Clinical Hospital № 1, Kyiv, Ukraine
2Kyiv Medical University of UAFM, Kyiv, Ukraine


SUMMARY

Problem. According to current observations, the increase in free cholesterol, low density lipoprotein and triglyceride levels associated with the risk of diabetic macular edema (DME).

Purpose. To study the effectiveness of pharmacological micronized fenofibrate, 145 mg in the complex treatment of patients with type II diabetes with diabetic macular edema.

Material and methods. Two groups of patients with diabetes type II and DME were investigated. In first group patients received the fenofibrate, 145 mg during 8 months and onetime intraocular injection of aflіbersept; in the second one – only intraocular injection of aflіbersept. Assessment of the retina produced in all terms by visual acuity and retinal thickness of macular area with optical coherence tomography Stratus-3000 with control of the lipid parameters in blood serum.

Results. In 8 months in group I, who obtained the drug fenofibrate, 145 mg, marked and more positive trend in ophthalmic and biochemical parameters and improve lipid profile were revealed.

Conclusion. The paper presents the results of the comparative analysis to determine the effectiveness of micronized fenofibrate (Traykor®145 mg) in complex microsurgical treatment of DME with the control of the dynamics of changes in lipid parameters of blood serum was done.

Keywords: diabetes, macular edema, blood lipid fractions.

Read more: Experience of the treatment of diabetic macular edema in patients with diabetes mellitus type II...

Page 5 of 6